These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37527510)

  • 21. Liquid Profiling of Circulating Nucleic Acids as a Novel Tool for the Management of Cancer Patients.
    Holdenrieder S
    Adv Exp Med Biol; 2016; 924():53-60. PubMed ID: 27753019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristic absorbance of nucleic acids in the Mid-IR region as possible common biomarkers for diagnosis of malignancy.
    Sahu RK; Argov S; Salman A; Huleihel M; Grossman N; Hammody Z; Kapelushnik J; Mordechai S
    Technol Cancer Res Treat; 2004 Dec; 3(6):629-38. PubMed ID: 15560721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the Influence of Nucleic Acid Backbone Modifications on Lipid Nanoparticle Morphology.
    An K; Kurek D; Mahadeo M; Zhang Y; Thewalt JL; Cullis PR; Kulkarni JA
    Langmuir; 2022 Nov; 38(46):14036-14043. PubMed ID: 36367350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards precision medicine: advances in 5-hydroxymethylcytosine cancer biomarker discovery in liquid biopsy.
    Zeng C; Stroup EK; Zhang Z; Chiu BC; Zhang W
    Cancer Commun (Lond); 2019 Mar; 39(1):12. PubMed ID: 30922396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mass Spectrometry for Investigating the Effects of Toxic Metals on Nucleic Acid Modifications.
    Xiong J; Yuan BF; Feng YQ
    Chem Res Toxicol; 2019 May; 32(5):808-819. PubMed ID: 30920205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic potential of circulating nucleic acids for oncology.
    Goessl C
    Expert Rev Mol Diagn; 2003 Jul; 3(4):431-42. PubMed ID: 12877383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of nucleic acid modifications by chemical reagents.
    Heiss M; Kellner S
    RNA Biol; 2017 Sep; 14(9):1166-1174. PubMed ID: 27901634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating nucleic acids in plasma/serum.
    Tsang JC; Lo YM
    Pathology; 2007 Apr; 39(2):197-207. PubMed ID: 17454749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Studies on nucleic acid metabolism. Molecular biology and clinical significance].
    Schöch G
    Fortschr Med; 1978 Oct; 96(37):1875-80. PubMed ID: 700570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liposomal delivery of nucleic acid-based anticancer therapeutics: BP-100-1.01.
    Ashizawa AT; Cortes J
    Expert Opin Drug Deliv; 2015 Jul; 12(7):1107-20. PubMed ID: 25539721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in modification and delivery of nucleic acid drugs.
    Wang J; Tan M; Wang Y; Liu X; Lin A
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 52(4):417-428. PubMed ID: 37643976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in biosensor development for the detection of cancer biomarkers.
    Jayanthi VSPKSA; Das AB; Saxena U
    Biosens Bioelectron; 2017 May; 91():15-23. PubMed ID: 27984706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic biomarkers in laboratory diagnostics: emerging approaches and opportunities.
    Sandoval J; Peiró-Chova L; Pallardó FV; García-Giménez JL
    Expert Rev Mol Diagn; 2013 Jun; 13(5):457-71. PubMed ID: 23782253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nucleic Acid Modifications in Regulation of Gene Expression.
    Chen K; Zhao BS; He C
    Cell Chem Biol; 2016 Jan; 23(1):74-85. PubMed ID: 26933737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrochemical nucleic acid sensors: Competent pathways for mobile molecular diagnostics.
    Bai H; Wang Y; Li X; Guo J
    Biosens Bioelectron; 2023 Oct; 237():115407. PubMed ID: 37295136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nucleic Acid Nanotechnology for Diagnostics and Therapeutics in Acute Kidney Injury.
    Ying Y; Tang Q; Han D; Mou S
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extracellular vesicle-mediated nucleic acid transfer and reprogramming in the tumor microenvironment.
    Parayath NN; Padmakumar S; Amiji MM
    Cancer Lett; 2020 Jul; 482():33-43. PubMed ID: 32289440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Capillary electrophoresis based on the nucleic acid detection in the application of human disease diagnosis.
    Lian DS; Zhao SJ
    Clin Lab; 2014; 60(8):1253-68. PubMed ID: 25185410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue and Cell-Free DNA-Based Epigenomic Approaches for Cancer Detection.
    Leal A; Sidransky D; Brait M
    Clin Chem; 2020 Jan; 66(1):105-116. PubMed ID: 31843869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The potential of DNA modifications as biomarkers and therapeutic targets in oncology.
    Jankowska AM; Millward CL; Caldwell CW
    Expert Rev Mol Diagn; 2015; 15(10):1325-37. PubMed ID: 26394702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.